Cargando…
A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis
SIMPLE SUMMARY: This study is one of the very few phase I trials on intraperitoneal chemotherapy applied as PIPAC. Cisplatin and doxorubicin may be safely used as PIPAC at a dose of 30 mg/m(2) and 6 mg/m(2), respectively; oxaliplatin can be used at an intraperitoneal dose of 135 mg/m(2). No serious...
Autores principales: | Robella, Manuela, De Simone, Michele, Berchialla, Paola, Argenziano, Monica, Borsano, Alice, Ansari, Shoeb, Abollino, Ornella, Ficiarà, Eleonora, Cinquegrana, Armando, Cavalli, Roberta, Vaira, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958944/ https://www.ncbi.nlm.nih.gov/pubmed/33802269 http://dx.doi.org/10.3390/cancers13051060 |
Ejemplares similares
-
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial
por: De Simone, Michele, et al.
Publicado: (2020) -
Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Metastases
por: Robella, Manuela, et al.
Publicado: (2021) -
Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis
por: Robella, Manuela, et al.
Publicado: (2016) -
Exploring the Use of Pegylated Liposomal Doxorubicin (Caelyx(®)) as Pressurized Intraperitoneal Aerosol Chemotherapy
por: Robella, Manuela, et al.
Publicado: (2019) -
Magnetic Iron Oxide Nanoparticles: Synthesis, Characterization and Functionalization for Biomedical Applications in the Central Nervous System
por: Ansari, Shoeb Anwar Mohammed Khawja, et al.
Publicado: (2019)